A proposed merger between Aetna and CVS has come under fire from the Association of American Physicians and Surgeons (AAPS).
In a letter to Attorney General Jeff Sessions, AAPS President-elect Marilyn Singleton, MD, JD, said that the merger would be bad for patients.
“Mergers can decrease competition and such mergers are not in the interest of our patients,” Singleton wrote.
The merger would combine the third-largest health insurer and the largest national pharmacy chain, which has the dominant pharmacy benefits manager (PBM), CVS Caremark, the AAPS wrote in a statement.
“This merger is particularly troubling in light of the highly concentrated national market for PBM services and current lack of transparency in drug pricing and PBM contracts,” Singleton wrote.
Full Content: PR Newswire, Insurance Business America
Featured News
Judge Partially Dismisses Investor Suit Against Google Over Ad Practices
Mar 25, 2025 by
CPI
UK Watchdog Scrutinizes Ticketmaster’s Dynamic Pricing Amid Oasis Ticket Controversy
Mar 25, 2025 by
CPI
Democratic Senators Urge White House to Seek Congressional Approval for TikTok Deadline Extension
Mar 25, 2025 by
CPI
Spain’s Antitrust Authority Probes Generali and Sanitas Over Competition Concerns
Mar 25, 2025 by
CPI
EU Lawmakers Warn Against Weakening AI Regulations
Mar 25, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mobile Ecosystems
Mar 24, 2025 by
CPI
Mobile Ecosystems: An Intellectual Entelechy but A Necessary Model
Mar 24, 2025 by
Alba Ribera Martinez
Creating Contestability and Fairness in Mobile Ecosystems: The Contribution of the DMA
Mar 24, 2025 by
Damien Geradin & Daniel Mandrescu
Digital Ecosystems and the Not (Yet) As Efficient Competitor Principle
Mar 24, 2025 by
Thomas Hoppner & Philipp Westerhoff
Assessing the Competition Law Scrutiny of Smart Wearables and Mobile AR/VR Devices
Mar 24, 2025 by
Kayvan Hazemi-Jebelli